# Brain Signal Training to Enhance Affect Down-regulation

> **NCT06626789** · PHASE1,PHASE2 · RECRUITING · sponsor: **Central Institute of Mental Health, Mannheim** · enrollment: 164 (estimated)

## Conditions studied

- Borderline Personality Disorder

## Interventions

- **BIOLOGICAL:** Amygdala neurofeedback
- **BEHAVIORAL:** Sham neurofeedback

## Key facts

- **NCT ID:** NCT06626789
- **Lead sponsor:** Central Institute of Mental Health, Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-23
- **Primary completion:** 2027-12
- **Final completion:** 2028-06
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06626789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06626789, "Brain Signal Training to Enhance Affect Down-regulation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06626789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*